SG

Sweety Garg

Active Director Director DIN 01917640
DIN 01917640 First appointment Feb 2006 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2006
Shareholding value •••• Premium profile

About Sweety Garg

Data last updated:

Sweety Garg is a Director at Ray Chem Medica Private Limited (since 2006). The company operates in Healthcare. Ray Chem Medica Private Limited reported revenue of ₹57.9 Lakh (FY 2024).

DIN 01917640
Primary Designation Director
Industry Healthcare
First Appointment 21 Feb 2006
Oldest Company Age 20 yrs
Largest company Ray Chem Medica Private Limited · ₹57.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ray Chem Medica Private Limited U33111DL2006PTC146606
Director21 Feb 20062006₹57.9 Lakh (FY 2024)Active

Board colleagues of Sweety Garg

NameDINCompanyDesignation
Naresh Kumar01917575Ray Chem Medica Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ray Chem Medica Private Limited
Premium access

Shareholding and investment profile for Sweety Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sweety Garg

Sweety Garg currently holds 1 directorship: Ray Chem Medica Private Limited (Director, since 21 Feb 2006, revenue ₹57.9 Lakh (FY 2024)).

Sweety Garg was first appointed on 21 Feb 2006 as Director at Ray Chem Medica Private Limited.

The current boards of Sweety Garg's companies include Naresh Kumar (Ray Chem Medica Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available